Osteoporosis
How Clinics Choose Osteoporosis Biologics in High-Risk Care
Collaborative Post When clinicians discuss Evenity and Prolia, the real issue is rarely a simple product comparison. It is a care-pathway decision shaped by fracture risk, the need for rapid skeletal protection, eligibility, monitoring burden, and the plan for treatment transition. That broader context matters in practice. In the clinic supply chain, organizations such as […]
Read more